EP3849977
IMPROVED METHOD FOR THE MANUFACTURE OF 3-[(1S)-1-IMIDAZO[1,2-A]PYRIDIN-6-YLETHYL]-5-(1-METHYLPYRAZOL-4-YL)TRIAZOLO[4,5-B]PYRAZINE AND POLYMORPHIC FORMS THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.9.2019EP published:
19.7.2023EP application number:
19769738.6
EPO information:
European Patent Register
Max expiry date:
9.9.2039
Title in English:
IMPROVED METHOD FOR THE MANUFACTURE OF 3-[(1S)-1-IMIDAZO[1,2-A]PYRIDIN-6-YLETHYL]-5-(1-METHYLPYRAZOL-4-YL)TRIAZOLO[4,5-B]PYRAZINE AND POLYMORPHIC FORMS THEREOFLanguage of the patent:
English
Timeline
Today
10.9.2019EP application
19.7.2023EP Publication
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Name:
Hutchison Medipharma LimitedAddress:
Building 4 720 Cai Lun Road Pilot Free Zone, Shanghai 201203, CN
Inventor
Name:
TURNER, Andrew, RoyAddress:
Macclesfield Cheshire SK10 2NA, GB
Name:
TURNER, Andrew, TimothyAddress:
Macclesfield Cheshire SK10 2NA, GB
Name:
HOWELL, Gareth, PaulAddress:
Macclesfield Cheshire SK10 2NA, GB
Name:
GALL, Malcolm, Allan, YoungAddress:
Macclesfield Cheshire SK10 2NA, GB
Name:
MULHOLLAND, Keith, RaymondAddress:
Macclesfield Cheshire SK10 2NA, GB
Name:
ADLINGTON, Neil, KeithAddress:
Macclesfield Cheshire SK10 2NA, GB
Name:
TIAN, ZhenpingAddress:
Jinan, Shandong 250100, CN
Name:
LIU, BoAddress:
Shanghai 201203, CN
Name:
GONG, QisunAddress:
Shanghai 201203, CN
Name:
YU, WeiAddress:
Shanghai 201203, CN
Priority
Number:
PCT/CN2018/104941Date:
11.9.2018Country:
WO
Classification
Categories:
C07D 471/04, C07D 519/00